Private Equity 3 Hours

Last updated: April 24, 2026, 8:30 AM ET

Private Equity Dealmaking & Strategy

Deal activity within the healthcare sector remains concentrated, with at least six recent transactions documented in orthopedic care, drawing investments from major firms including Archimed, Cinven, Gemspring, and InTandem. This investment trend follows similar specialist roll-ups seen across other fragmented medical verticals. Elsewhere in the deal space, the Avance-backed Alchemy Technology Group continued its vertical integration strategy by acquiring cybersecurity specialist IOvations, signaling continued private equity appetite for specialized IT advisory and reseller services in the Houston market.

Personnel & Fundraising Moves

Manna Tree announced the appointment of Jessica Schmitt as Managing Director of Capital Formation, tasking her with steering the firm’s global investor relations and supporting expansion driven by rising consumer demand for health-focused investments. This strategic hiring comes as fundraising dynamics present challenges in certain regions; for instance, Japanese limited partners are expressing caution regarding the credit secondaries market due to perceived information asymmetry and a lack of necessary look-through data, according to discussions at the Private Debt Investor Tokyo Forum.

Technology Sector M&A and Exits

The technology exit environment is showing tentative signs of life, with a growing number of venture-backed companies filing S-1 documents for public listings, spanning areas from semiconductors and biotech to space and defense tech. This pipeline buildup suggests firms are preparing for a potential uptake in IPO volume. Separately, the European AI sector saw a major consolidation as Aleph Alpha struck a $20 billion merger deal with Canadian rival Cohere, marking a significant move in the race to build foundational large language models against established U.S. competitors.